AMPICLOVAC CAP

AMPICLOVAC CAP contains a synergistic combination of Ampicillin and Cloxacillin, providing broad-spectrum antibacterial coverage against both Gram-positive and Gram-negative bacteria, including β-lactamase-producing strains.

Key Features:

• Composition: Ampicillin + Cloxacillin (typically 250 mg each per capsule)

• Effective against resistant and mixed bacterial infections

• Dual mechanism: Ampicillin targets a wide bacterial range, Cloxacillin resists β-lactamase enzymes

• Ideal for both community and hospital-acquired infections

Indications:

• Respiratory tract infections (e.g., bronchitis, tonsillitis, pneumonia)

• Skin and soft tissue infections

• Bone and joint infections

• ENT infections

• Urinary tract infections (UTIs)

• Post-surgical and wound infections